ESR2 and neoplasm: Some scholars believe that the upregulation of EsRβ can inhibit the expressions of IRE1 and XBP1, increase the sensitivity of tumor cells to tamoxifen, and cause the apoptosis of chemoresistant cells (Rajapaksa et al., 2015).